ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
20 Oct 2017 Annals of Oncology Press Release: Oral Sex and Smoking Increase Men’s Risk of Head and Neck Cancer But the Risk is Still Low, Making Screening for the Disease a Challenge
19 Oct 2017 ESMO Press Release: Cancer Outcome Depends on Complex Interactions Between Many Mutations
19 Oct 2017 ESMO Press Release: First ESMO Award in Immuno-Oncology Goes to Laurence Zitvogel
14 Sep 2017 ESMO Press Release: ESMO announces new interim Editor-in-Chief of Annals of Oncology
12 Sep 2017 ESMO 2017 Press Release: Best of ESMO 2017 Congress
12 Sep 2017 ESMO 2017 Press Release: Best Poster at ESMO 2017 Shows Positive Trials Twice as Likely to be Reported in Lay Press
11 Sep 2017 ESMO 2017 Press Release: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma Melanoma and other skin tumours
11 Sep 2017 ESMO 2017 Press Release: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma Melanoma and other skin tumours
11 Sep 2017 ESMO 2017 Press Release: Debate on Duration of Colon Cancer Adjuvant Chemotherapy Takes Centre Stage at ESMO 2017 Gastrointestinal cancers
11 Sep 2017 ESMO 2017 Press Release: KEYNOTE-040 Evaluates Pembrolizumab in Head and Neck Cancer Head and neck cancers
10 Sep 2017 ESMO 2017 Media Alert: ESMO 2017 Shows Support for World Cancer Research Day
10 Sep 2017 ESMO 2017 Press Release: Mature Results Favour Pembrolizumab As Second-line Treatment For Bladder Cancer Genitourinary cancers
10 Sep 2017 ESMO 2017 Press Release: Licensing and Reimbursement Discrepancies Impact Patient Access to Cancer Treatment
10 Sep 2017 ESMO 2017 Press Release: Combination Immunotherapy in Second/third Line Extends Mesothelioma Survival to 15 Months Lung and other thoracic tumours
10 Sep 2017 ESMO 2017 Press Release: Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer Breast cancer